C
Christof Schöfl
Researcher at University of Erlangen-Nuremberg
Publications - 49
Citations - 2313
Christof Schöfl is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Acromegaly & Calcium-sensing receptor. The author has an hindex of 25, co-authored 49 publications receiving 1992 citations. Previous affiliations of Christof Schöfl include Charité.
Papers
More filters
Journal ArticleDOI
Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20–79
Robin Haring,Henry Völzke,Antje Steveling,Alexander Krebs,Stephan B. Felix,Christof Schöfl,Marcus Dörr,Matthias Nauck,Henri Wallaschofski +8 more
TL;DR: Low serum testosterone levels were associated with an increased risk of all-cause mortality independent of numerous risk factors, and may be used as a predictive marker in men aged 20-79.
Journal ArticleDOI
23Na Magnetic Resonance Imaging of Tissue Sodium
Christoph W. Kopp,Peter Linz,Lydia Wachsmuth,Anke Dahlmann,Thomas Horbach,Christof Schöfl,Wolfgang Renz,Davide Santoro,Thoralf Niendorf,Dominik N. Müller,Myriam Neininger,Alexander Cavallaro,Kai-Uwe Eckardt,Roland E. Schmieder,Friedrich C. Luft,Michael Uder,Jens Titze +16 more
TL;DR: It is suggested that, after further refinements, this tool could facilitate understanding the relationships between Na+ accumulation and hypertension, and with additional technical advances, a future clinical use may be possible.
Journal ArticleDOI
A high normal TSH is associated with the metabolic syndrome
S Ruhla,Martin O. Weickert,Ayman M. Arafat,Martin A. Osterhoff,Frank Isken,Joachim Spranger,Christof Schöfl,Christof Schöfl,Andreas Pfeiffer,Matthias Möhlig +9 more
TL;DR: This work investigated the associations between TSH and the features and prevalence of the metabolic syndrome in euthyroid German subjects and found that TSH is associated with obesity and insulin resistance but the prevalence of these features is low.
Journal ArticleDOI
Growth Hormone Response during Oral Glucose Tolerance Test: The Impact of Assay Method on the Estimation of Reference Values in Patients with Acromegaly and in Healthy Controls, and the Role of Gender, Age, and Body Mass Index
Ayman M. Arafat,Matthias Möhlig,Martin O. Weickert,Frank H. Perschel,Johannes Purschwitz,Joachim Spranger,Christian J. Strasburger,Christof Schöfl,Christof Schöfl,Andreas Pfeiffer +9 more
TL;DR: Postglucose GH-nadir values are assay, gender, age, and BMI specific, indicating the need of individual cutoff limits for each assay.
Journal ArticleDOI
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial.
André Lacroix,Feng Gu,Wilson Gallardo,Rosario Pivonello,Yerong Yu,Przemysław Witek,Marco Boscaro,Roberto Salvatori,Masanobu Yamada,Libuse Tauchmanova,Michael Roughton,Shoba Ravichandran,Stephan Petersenn,Beverly M. K. Biller,John Newell-Price,Giorgio Arnaldi,Hesarghatta Shyamasunder Asha,Tushar Bandgar,Ariel L. Barkan,Henrik Biering,Marie Bex,Marek Bolanowski,Marcello D. Bronstein,Thierry Brue,Dario Bruera,Francesco Cavagnini,Abdurrahman Comlekci,Christophe De Block,Tuncay Delibasi,Carmen Fajardo-Montañana,Richard A Feelders,Maria Fleseriu,Mônica R. Gadelha,Eliza B Geer,Anthony P. Heaney,Ghislaine Houde,Atsuhiro Ichihara,Syed Ali Imran,Adriana G. Ioachimescu,Pinar Kadioglu,Yiming Li,Paola Loli,Mitsuru Nishiyama,Liudmila Rozhinskaya,Marek Ruchała,Youichi Saitoh,Christof Schöfl,Jochen Schopohl,Akira Shimatsu,Chikara Shimizu,Thiti Snabboon,Peter J. Snyder,Noriyuki Suzaki,Antoine Tabarin,Yutaka Takahashi,Susana Tara Britto,Guy T'Sjoen,Marie-Christine Vantyghem,Brigitte Velkeniers,Susan M. Webb,Shozo Yamada +60 more
TL;DR: Long-acting pasireotide is an efficacious treatment option for some patients with Cushing's disease who have persistent or recurrent disease after initial surgery or are not surgical candidates, and provides a convenient monthly administration schedule.